Case Study

Diagnosing Subclinical Hypothyroidism Missed by Standard NHS Testing

A woman in her early 40s had complained of fatigue, weight gain, and brain fog for two years. Every GP visit ended the same way: stress, lifestyle, maybe depression. A targeted assessment revealed what NHS screening had missed entirely.

The Situation

The client was a woman in her early 40s experiencing persistent fatigue, unexplained weight gain of 8kg over 18 months, and cognitive fog that was affecting her work. She had seen her GP three times over two years with these complaints. Each time, routine blood work came back normal. The diagnosis was stress and lifestyle, with suggestions to exercise more and sleep better.

She knew something was wrong. Her mother had Hashimoto's, and the pattern felt familiar. But with normal test results, there was nowhere to go within the NHS system.

What We Did

We reviewed her GP blood work. It showed TSH at 2.8 mIU/L and free T4 at 14.5 pmol/L, both technically within range. But her free T3 had never been measured. Neither had thyroid antibodies. The NHS protocol uses TSH as the primary marker, and until it crosses a threshold, secondary testing is rarely done.

We commissioned a comprehensive thyroid panel including free T3, TPO antibodies, and thyroglobulin antibodies. We also reviewed her symptom timeline and family history in detail.

What Changed

The extended testing revealed significantly elevated TPO antibodies at 247 IU/mL, indicating Hashimoto's thyroiditis. Free T3 was at the lower end of normal at 3.1 pmol/L. Combined with her symptoms, clinical presentation, and family history, the diagnosis was subclinical hypothyroidism secondary to autoimmune thyroid disease, a pattern the standard NHS screening simply could not detect.

Her GP, presented with this evidence, initiated treatment with levothyroxine at 25mcg, with a titration plan based on response. Within 8 weeks, energy levels improved measurably. By 12 weeks, cognitive function had normalised and her weight began to stabilise.

Outcome

Full symptom resolution within 4 months. TSH optimised at 1.2 mIU/L on a stable dose. She returned to exercise, her concentration improved, and weight stabilised at 6kg loss. More importantly, early detection and treatment prevented progression to overt hypothyroidism.

All case studies are anonymised composites based on real scenarios. Details changed to protect confidentiality. Individual outcomes vary.

Facing unexplained symptoms that standard tests miss?

Begin a Private Inquiry